Prioritizing the glucose-lowering medicines for type 2 diabetes by an extended fuzzy decision-making approach with target-based attributes.
Different therapeutic classes have been authorized for the treatment of hyperglycemia in type 2 diabetic patients, and even more drug classes are under development. This variety of alternative treatments and the general treatment algorithms of the clinical guidelines lead to a nonuniform prescriptio...
| Publicado en: | Medical & Biological Engineering & Computing Vol. 60; no. 8; pp. 2423 - 2445 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Aug2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |